Davenport & Co’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226M Sell
542,271
-259,439
-32% -$96.2M 1.11% 12
2026
Q1
$215M Buy
801,710
+129,294
+19% +$38.5M 1.17% 10
2025
Q4
$222M Sell
672,416
-67,109
-9% -$22.7M 1.18% 11
2025
Q3
$255M Buy
739,525
+155,551
+27% +$47M 1.36% 9
2025
Q2
$182M Buy
583,974
+141,258
+32% +$54M 0.99% 14
2025
Q1
$231M Buy
442,716
+22,936
+5% +$11.7M 1.34% 10
2024
Q4
$212M Buy
419,780
+81,585
+24% +$46.4M 1.2% 11
2024
Q3
$198M Buy
338,195
+7,493
+2% +$4.24M 1.12% 13
2024
Q2
$167M Buy
330,702
+56,995
+21% +$27.9M 1.01% 18
2024
Q1
$135M Buy
273,707
+29,917
+12% +$15.2M 0.83% 25
2023
Q4
$128M Sell
243,790
-299
-0.1% -$159K 0.87% 26
2023
Q3
$123M Buy
244,089
+54,521
+29% +$26.8M 0.93% 22
2023
Q2
$90.9M Sell
189,568
-3,343
-2% -$1.63M 0.67% 48
2023
Q1
$91M Sell
192,911
-721
-0.4% -$348K 0.71% 45
2022
Q4
$102M Sell
193,632
-1,540
-0.8% -$816K 0.84% 28
2022
Q3
$98.6M Sell
195,172
-3,066
-2% -$1.61M 0.86% 27
2022
Q2
$102M Sell
198,238
-2,684
-1% -$1.35M 0.83% 35
2022
Q1
$103M Buy
200,922
+704
+0.4% +$340K 0.7% 46
2021
Q4
$101M Buy
200,218
+4,677
+2% +$2.12M 0.66% 47
2021
Q3
$76.4M Buy
195,541
+27,626
+16% +$11.4M 0.54% 63
2021
Q2
$67.2M Sell
167,915
-15,099
-8% -$6.02M 0.52% 72
2021
Q1
$68.1M Buy
183,014
+155,259
+559% +$53.8M 0.64% 53
2020
Q4
$9.73M Buy
27,755
+1,711
+7% +$574K 0.1% 133
2020
Q3
$8.12M Sell
26,044
-1,624
-6% -$499K 0.09% 134
2020
Q2
$8.16M Sell
27,668
-37
-0.1% -$10.6K 0.1% 128
2020
Q1
$6.91M Sell
27,705
-1,335
-5% -$367K 0.1% 127
2019
Q4
$8.54M Buy
29,040
+4,517
+18% +$1.18M 0.09% 137
2019
Q3
$5.98M Sell
24,523
-165
-0.7% -$39.8K 0.07% 149
2019
Q2
$6.02M Sell
24,688
-674
-3% -$162K 0.07% 146
2019
Q1
$6.27M Buy
25,362
+63
+0.2% +$16.1K 0.08% 142
2018
Q4
$6.3M Buy
25,299
+422
+2% +$111K 0.09% 139
2018
Q3
$6.62M Buy
24,877
+5,845
+31% +$1.52M 0.08% 151
2018
Q2
$4.67M Buy
19,032
+429
+2% +$103K 0.06% 165
2018
Q1
$3.98M Buy
18,603
+834
+5% +$190K 0.05% 171
2017
Q4
$3.92M Buy
17,769
+300
+2% +$63.6K 0.05% 172
2017
Q3
$3.42M Sell
17,469
-68
-0.4% -$13.1K 0.04% 175
2017
Q2
$3.25M Buy
17,537
+4,088
+30% +$717K 0.04% 175
2017
Q1
$2.15M Sell
13,449
-300
-2% -$49.1K 0.03% 204
2016
Q4
$2.2M Buy
13,749
+2,746
+25% +$410K 0.03% 196
2016
Q3
$1.54M Sell
11,003
-265
-2% -$37.1K 0.02% 234
2016
Q2
$1.59M Buy
11,268
+250
+2% +$33.3K 0.02% 227
2016
Q1
$1.42M Sell
11,018
-618
-5% -$73.1K 0.02% 234
2015
Q4
$1.37M Sell
11,636
-8,010
-41% -$936K 0.02% 234
2015
Q3
$2.28M Buy
19,646
+595
+3% +$71.2K 0.04% 190
2015
Q2
$2.32M Sell
19,051
-1,715
-8% -$203K 0.04% 199
2015
Q1
$2.46M Sell
20,766
-315
-1% -$35K 0.04% 207
2014
Q4
$2.13M Buy
21,081
+7,620
+57% +$722K 0.03% 208
2014
Q3
$1.16M Buy
13,461
+175
+1% +$14.8K 0.02% 258
2014
Q2
$1.09M Sell
13,286
-288
-2% -$22.7K 0.02% 268
2014
Q1
$1.11M Buy
13,574
+10,300
+315% +$775K 0.02% 252
2013
Q4
$247K Buy
3,274
+256
+8% +$18.4K ﹤0.01% 486
2013
Q3
$216K Buy
+3,018
New +$216K ﹤0.01% 492

Other funds holding UNH

Davenport & Co's UNH Position: Q2 2026 in Review

Davenport & Co reduced its UnitedHealth (UNH) stake by 32% in Q2 2026, selling an estimated $96.2M and leaving 542,271 shares worth $226M. The position accounts for 1.11% of the portfolio, ranked #12.

Davenport & Co first reported a position in UNH in Q3 2013 and has held it in 52 quarters since. The position peaked at $255M in Q3 2025. 568 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Davenport & Co held 542,271 shares of UnitedHealth worth $226M as of Q2 2026.
  • Davenport & Co sold 259,439 UnitedHealth shares in Q2 2026, an estimated $96.2M.
  • UnitedHealth made up 1.11% of Davenport & Co's portfolio in Q2 2026, its #12 holding.
  • Davenport & Co first reported a position in UnitedHealth in Q3 2013 and has held it in 52 quarters since.
  • Davenport & Co's UnitedHealth position peaked at $255M in Q3 2025.
  • 568 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.